Literature DB >> 19996764

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses.

Stéphanie Raymond1, Pierre Delobel, Maud Mavigner, Laurent Ferradini, Michelle Cazabat, Corinne Souyris, Karine Sandres-Sauné, Christophe Pasquier, Bruno Marchou, Patrice Massip, Jacques Izopet.   

Abstract

BACKGROUND: Genotypic predictions of HIV-1 tropism could simplify CCR5 antagonist usage. However, the genotypic algorithms built from subtype B viruses could be inadequate for non-B subtypes. We therefore performed paired genotypic and phenotypic determination of subtype C tropism.
METHODS: We studied 52 patients recruited in Malawi and 21 patients recruited in France. We directly sequenced the V3 env region and performed a recombinant virus phenotypic entry assay in parallel.
RESULTS: The Malawi patients had 29% of CXCR4-using subtype C viruses compared with only 5% in the patients from France. For detecting CXCR4-using subtype C viruses, the genotypic rule combining the amino acids at positions 11/25 and the net charge of V3 was 93.3% sensitive and 96.4% specific. The Geno2pheno tool was 86.7% sensitive and 89.1% specific. The WebPSSM tool with the SI/NSI matrix was 80% sensitive and 98.2% specific in its subtype B version and 93.3% sensitive and 81.8% specific in its subtype C version.
CONCLUSIONS: The genotypic determinants of coreceptor usage for HIV-1 subtype C were mainly in V3 and were globally similar to those previously reported for subtype B viruses. The main genotypic algorithms built from subtype B viruses perform well when applied to subtype C viruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19996764     DOI: 10.1097/QAI.0b013e3181c8413b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  26 in total

1.  Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection.

Authors:  Pierre Frange; Marie-Laure Chaix; Stéphanie Raymond; Julie Galimand; Christiane Deveau; Laurence Meyer; Cécile Goujard; Christine Rouzioux; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

2.  Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.

Authors:  Patricia Recordon-Pinson; Cathia Soulié; Philippe Flandre; Diane Descamps; Mouna Lazrek; Charlotte Charpentier; Brigitte Montes; Mary-Anne Trabaud; Jacqueline Cottalorda; Véronique Schneider; Laurence Morand-Joubert; Catherine Tamalet; Delphine Desbois; Muriel Macé; Virginie Ferré; Astrid Vabret; Annick Ruffault; Coralie Pallier; Stéphanie Raymond; Jacques Izopet; Jacques Reynes; Anne-Geneviève Marcelin; Bernard Masquelier
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

3.  Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India.

Authors:  Ujjwal Neogi; Sreenivasa B Prarthana; George D'Souza; Ayesha Decosta; Vijesh S Kuttiatt; Udaykumar Ranga; Anita Shet
Journal:  AIDS Res Ther       Date:  2010-07-21       Impact factor: 2.250

4.  Algorithm-based prediction of HIV-1 subtype D coreceptor use.

Authors:  Julia Dina; Stephanie Raymond; Anne Maillard; Helene Le Guillou-Guillemette; Audrey Rodalec; Agnes Beby-Defaux; Genevieve Giraudeau; Sophie Vallet; Thomas Mourez; Christopher Payan; Astrid Vabret; Annick Ruffault; Virginie Ferre; Jacques Izopet; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

5.  Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.

Authors:  Taryn N Green; Mohendran Archary; Michelle L Gordon; Nagavelli Padayachi; Yolanda Lie; Elizabeth D Anton; Jacqueline D Reeves; Anneke Grobler; Raziya Bobat; Hoosen Coovadia; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-05       Impact factor: 2.205

6.  Comparison of population and 454 "deep" sequence analysis for HIV type 1 tropism versus the original trofile assay in non-B subtypes.

Authors:  Guinevere Q Lee; P Richard Harrigan; Winnie Dong; Art F Y Poon; Jayvant Heera; James Demarest; Alex Rinehart; Doug Chapman; Hernan Valdez; Simon Portsmouth
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-06       Impact factor: 2.205

7.  Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.

Authors:  Ishla Seager; Simon A Travers; Michael D Leeson; Amelia C Crampin; Neil French; Judith R Glynn; Grace P McCormack
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-29       Impact factor: 2.205

8.  Genotypic prediction of HIV-1 CRF01-AE tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Sylvie Rogez; Stéphanie Encinas; Patrick Bruel; Christophe Pasquier; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

9.  Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.

Authors:  Mattia C F Prosperi; Laura Bracciale; Massimiliano Fabbiani; Simona Di Giambenedetto; Francesca Razzolini; Genny Meini; Manuela Colafigli; Angela Marzocchetti; Roberto Cauda; Maurizio Zazzi; Andrea De Luca
Journal:  Retrovirology       Date:  2010-06-30       Impact factor: 4.602

10.  Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.

Authors:  Ron M Kagan; Erik P Johnson; Martin F Siaw; Ben Van Baelen; Richard Ogden; Jamie L Platt; Rick L Pesano; Eric Lefebvre
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-14       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.